BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 24997323)

  • 21. Development of a novel azaspirane that targets the Janus kinase-signal transducer and activator of transcription (STAT) pathway in hepatocellular carcinoma in vitro and in vivo.
    Mohan CD; Bharathkumar H; Bulusu KC; Pandey V; Rangappa S; Fuchs JE; Shanmugam MK; Dai X; Li F; Deivasigamani A; Hui KM; Kumar AP; Lobie PE; Bender A; Basappa ; Sethi G; Rangappa KS
    J Biol Chem; 2014 Dec; 289(49):34296-307. PubMed ID: 25320076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3.
    Subramaniam A; Shanmugam MK; Ong TH; Li F; Perumal E; Chen L; Vali S; Abbasi T; Kapoor S; Ahn KS; Kumar AP; Hui KM; Sethi G
    Br J Pharmacol; 2013 Oct; 170(4):807-21. PubMed ID: 23848338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of antitumor activity of Artemisia capillaris extract against hepatocellular carcinoma through the inhibition of IL-6/STAT3 signaling axis.
    Jang E; Kim SY; Lee NR; Yi CM; Hong DR; Lee WS; Kim JH; Lee KT; Kim BJ; Lee JH; Inn KS
    Oncol Rep; 2017 Jan; 37(1):526-532. PubMed ID: 28004112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3.
    Chen KF; Chen HL; Liu CY; Tai WT; Ichikawa K; Chen PJ; Cheng AL
    Biochem Pharmacol; 2012 Mar; 83(6):769-77. PubMed ID: 22230479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-124 suppresses growth of human hepatocellular carcinoma by targeting STAT3.
    Lu Y; Yue X; Cui Y; Zhang J; Wang K
    Biochem Biophys Res Commun; 2013 Nov; 441(4):873-9. PubMed ID: 24211205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway.
    Zhao H; Guo Y; Li S; Han R; Ying J; Zhu H; Wang Y; Yin L; Han Y; Sun L; Wang Z; Lin Q; Bi X; Jiao Y; Jia H; Zhao J; Huang Z; Li Z; Zhou J; Song W; Meng K; Cai J
    Oncotarget; 2015 Oct; 6(31):31927-43. PubMed ID: 26376676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of signal transducer and activator of transcription 3 activation by butein inhibits growth of human hepatocellular carcinoma in vivo.
    Rajendran P; Ong TH; Chen L; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Sharma A; Kumar AP; Hui KM; Sethi G
    Clin Cancer Res; 2011 Mar; 17(6):1425-39. PubMed ID: 21131551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The anti-hepatocellular carcinoma effect of Brucea javanica oil in ascitic tumor-bearing mice: The detection of brusatol and its role.
    Wang T; Dou Y; Lin G; Li Q; Nie J; Chen B; Xie J; Su Z; Zeng H; Chen J; Xie Y
    Biomed Pharmacother; 2021 Feb; 134():111122. PubMed ID: 33341052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brucine, an alkaloid from seeds of Strychnos nux-vomica Linn., represses hepatocellular carcinoma cell migration and metastasis: the role of hypoxia inducible factor 1 pathway.
    Shu G; Mi X; Cai J; Zhang X; Yin W; Yang X; Li Y; Chen L; Deng X
    Toxicol Lett; 2013 Oct; 222(2):91-101. PubMed ID: 23933019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morusin shows potent antitumor activity for human hepatocellular carcinoma in vitro and in vivo through apoptosis induction and angiogenesis inhibition.
    Gao L; Wang L; Sun Z; Li H; Wang Q; Yi C; Wang X
    Drug Des Devel Ther; 2017; 11():1789-1802. PubMed ID: 28670112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polysaccharide from Lentinus edodes combined with oxaliplatin possesses the synergy and attenuation effect in hepatocellular carcinoma.
    Zhang Y; Li Q; Wang J; Cheng F; Huang X; Cheng Y; Wang K
    Cancer Lett; 2016 Jul; 377(2):117-25. PubMed ID: 27130669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sesamin induces cell cycle arrest and apoptosis through the inhibition of signal transducer and activator of transcription 3 signalling in human hepatocellular carcinoma cell line HepG2.
    Deng P; Wang C; Chen L; Wang C; Du Y; Yan X; Chen M; Yang G; He G
    Biol Pharm Bull; 2013; 36(10):1540-8. PubMed ID: 24088253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo conditional sensitization of hepatocellular carcinoma cells to TNF-induced apoptosis by taxol.
    Minero VG; De Stefanis D; Costelli P; Baccino FM; Bonelli G
    Cell Cycle; 2015; 14(7):1090-102. PubMed ID: 25564714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. STAT3 mediates regorafenib-induced apoptosis in hepatocellular carcinoma.
    Tai WT; Chu PY; Shiau CW; Chen YL; Li YS; Hung MH; Chen LJ; Chen PL; Su JC; Lin PY; Yu HC; Chen KF
    Clin Cancer Res; 2014 Nov; 20(22):5768-76. PubMed ID: 25248379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nintedanib (BIBF-1120) inhibits hepatocellular carcinoma growth independent of angiokinase activity.
    Tai WT; Shiau CW; Li YS; Chang CW; Huang JW; Hsueh TT; Yu HC; Chen KF
    J Hepatol; 2014 Jul; 61(1):89-97. PubMed ID: 24657398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. V8, a newly synthetic flavonoid, induces apoptosis through ROS-mediated ER stress pathway in hepatocellular carcinoma.
    Zhang Y; Zhao L; Li X; Wang Y; Yao J; Wang H; Li F; Li Z; Guo Q
    Arch Toxicol; 2014 Jan; 88(1):97-107. PubMed ID: 23835921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumor immunostimulatory activity of polysaccharides from Salvia chinensis Benth.
    Shu G; Zhao W; Yue L; Su H; Xiang M
    J Ethnopharmacol; 2015 Jun; 168():237-47. PubMed ID: 25858511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2.
    Xu D; Jin J; Yu H; Zhao Z; Ma D; Zhang C; Jiang H
    J Exp Clin Cancer Res; 2017 Mar; 36(1):44. PubMed ID: 28320429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.
    Zheng L; Yang W; Wu F; Wang C; Yu L; Tang L; Qiu B; Li Y; Guo L; Wu M; Feng G; Zou D; Wang H
    Clin Cancer Res; 2013 Oct; 19(19):5372-80. PubMed ID: 23942093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor activity of tatariside F isolated from roots of Fagopyrum tataricum (L.) Gaertn against H22 hepatocellular carcinoma via up-regulation of p53.
    Peng W; Hu C; Shu Z; Han T; Qin L; Zheng C
    Phytomedicine; 2015 Jul; 22(7-8):730-6. PubMed ID: 26141759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.